Skip to main content

Table 1 Patient characteristics (n = 33)

From: Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

Characteristics

Number

 

Age, years

  

  Median (range)

67

(54–86)

Sex

  

  Male/female

18/15

 

Performance status

  

  0/1/2

2/28/3

 

Clinical stage

  

  III/IV

6/27

 

Histology

  

  Ad/Sq/La

29/3/1

 

EGFR mutation status

  

  Ex18 del/ Ex19 del/ Ex21L858R

1/9/9

 

  Negative

9

 

  Unknown

5

 

Brinkman index

  

  Median (range)

370

(0–3840)

Body mass index, Kg/m2

  

Median (range)

23.0

(16.0–29.8)

Concomitant disease

  

  rheumatoid arthritis

1

 

  diabetes mellitus

6

 

  hyperlipidemia

6

 

  hypertension

17

 

Treatment line

  

  1st/2nd/more

3/19/11

 
  1. EGFR, Epidermal growth factor receptor; Ad, Adenocarcinoma; Sq, Squamous cell carcinoma, La, Large-cell carcinoma; Ex, Exon; del, Deletion.